cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.6269768.v1
title: Psoriasis Patient Resources

description: <strong>Article full text</strong>The full text versions of all of these articles within this Topical Collection can be found <b>here. </b>https://link.springer.com/journal/13555/topicalCollection/AC_7fe0c06d51bf15e930b6cda6b462602c<br><strong>Provide enhanced content for this article</strong><br>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com.<br><br>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br><br>Other enhanced features include, but are not limited to:<br>• Videos and animations<br>• Audio abstracts<br>• Audio slides
DOI: 10.6084/m9.figshare.6269747
title: fig 10

description: dispersion
DOI: 10.6084/m9.figshare.6269747.v1
title: fig 10

description: dispersion
DOI: 10.6084/m9.figshare.6269744
title: Fig. 9

description: deformability constant
DOI: 10.6084/m9.figshare.6269744.v1
title: Fig. 9

description: deformability constant
DOI: 10.6084/m9.figshare.6269738
title: Supplementary Material for: Passive Hydrotherapy WATSU® for Rehabilitation of an Accident Survivor: A Prospective Case Report

description: Background: WaterShiatsu (WATSU) is a passive form of hydrotherapy in warm water (35 ° C) that aims at relaxation, pain relief, and a sense of security. This case report focuses on a patient’s experience of integrating WATSU into her rehabilitative care. Case Report: A 52-year-old woman survived a severe motorcycle accident in which she sustained several fractures on the right side of her body, including ribs, the pelvis, and the femur. After discharge from stationary care, she independently scheduled 8 weekly WATSU sessions with an experienced WATSU therapist also trained in physiotherapy and psychosomatics. Quantitative and qualitative data obtained from the patient’s diary and the therapist’s notes is presented. Results: The patient associated WATSU with physical and emotional release, reconciliation with her body, and trunk mobilization (followed by ameliorated breath). She ascribed WATSU lasting effects on her body image and reported continuous improvement by the Patient-Specific Functional Scale. The therapist employed WATSU to equalize awareness throughout the body and for careful mobilization. Due to complications (elevated inflammation markers), only 6 of 8 scheduled sessions were administered. Conclusions: WATSU was experienced as helpful in approaching a condition that the patient felt insufficiently covered by conventional physiotherapy alone. In early rehabilitation, additional medical/ physiotherapeutic skills of contributing complementary therapists are advocated.
DOI: 10.6084/m9.figshare.6269738.v1
title: Supplementary Material for: Passive Hydrotherapy WATSU® for Rehabilitation of an Accident Survivor: A Prospective Case Report

description: Background: WaterShiatsu (WATSU) is a passive form of hydrotherapy in warm water (35 ° C) that aims at relaxation, pain relief, and a sense of security. This case report focuses on a patient’s experience of integrating WATSU into her rehabilitative care. Case Report: A 52-year-old woman survived a severe motorcycle accident in which she sustained several fractures on the right side of her body, including ribs, the pelvis, and the femur. After discharge from stationary care, she independently scheduled 8 weekly WATSU sessions with an experienced WATSU therapist also trained in physiotherapy and psychosomatics. Quantitative and qualitative data obtained from the patient’s diary and the therapist’s notes is presented. Results: The patient associated WATSU with physical and emotional release, reconciliation with her body, and trunk mobilization (followed by ameliorated breath). She ascribed WATSU lasting effects on her body image and reported continuous improvement by the Patient-Specific Functional Scale. The therapist employed WATSU to equalize awareness throughout the body and for careful mobilization. Due to complications (elevated inflammation markers), only 6 of 8 scheduled sessions were administered. Conclusions: WATSU was experienced as helpful in approaching a condition that the patient felt insufficiently covered by conventional physiotherapy alone. In early rehabilitation, additional medical/ physiotherapeutic skills of contributing complementary therapists are advocated.
DOI: 10.6084/m9.figshare.6269735
title: Fig. 8

description: electrical conductivity
DOI: 10.6084/m9.figshare.6269735.v1
title: Fig. 8

description: electrical conductivity
DOI: 10.6084/m9.figshare.12885089.v1
title: Table_S4

description: Values of depurination in the 28S rRNA sequences of D. melanogaster. Number of adenines or other bases in the specific site of RIP attack in the presence of Spiroplasma (S+W0) or in absence of Spiroplasma (S0W0), respectively. The two times of parasitism were evaluated, T1=24h PWA and T2=72 PWA.
DOI: 10.6084/m9.figshare.12885074
title: Table_S3

description: Values of depurination in the 28S rRNA sequences of L. heterotoma or G. hookeri. Number of adenines or other bases in the specific site of RIP attack in the presence of Spiroplasma-L. heterotoma(S+Lh), Spiroplasma-G. hookeri(S+Gh) or in absence of Spiroplasma (S0Lh and S0Gh), respectively. The two times of parasitism were evaluated, T1=24h PWA and T2=72 PWA
DOI: 10.6084/m9.figshare.12885068
title: Table_S1

description: Parameters used to run the simulations of the power analyses. Different combinations of parameters were evaluated. Coverages and Coefficient of Biological (BCV; estimated by edgeR) were inferred from our datasets.
DOI: 10.6084/m9.figshare.12885089
title: Table_S4

description: Values of depurination in the 28S rRNA sequences of D. melanogaster. Number of adenines or other bases in the specific site of RIP attack in the presence of Spiroplasma (S+W0) or in absence of Spiroplasma (S0W0), respectively. The two times of parasitism were evaluated, T1=24h PWA and T2=72 PWA.
DOI: 10.6084/m9.figshare.12885071
title: Table_S2

description: Mapping statistics of all treatments including replicates. Table contains the number of reads aligned to D. melanogaster or Spiroplasma genome. Library sizes determined by edgeR of competitive or noncompetitive alignments. Number of reads that align to fly ribosomal sequences (28S and 18S). Numbers of reads that align to Spiroplasma genome and coverage by replicate.
DOI: 10.6084/m9.figshare.12885068.v1
title: Table_S1

description: Parameters used to run the simulations of the power analyses. Different combinations of parameters were evaluated. Coverages and Coefficient of Biological (BCV; estimated by edgeR) were inferred from our datasets.
DOI: 10.6084/m9.figshare.12885071.v1
title: Table_S2

description: Mapping statistics of all treatments including replicates. Table contains the number of reads aligned to D. melanogaster or Spiroplasma genome. Library sizes determined by edgeR of competitive or noncompetitive alignments. Number of reads that align to fly ribosomal sequences (28S and 18S). Numbers of reads that align to Spiroplasma genome and coverage by replicate.
DOI: 10.6084/m9.figshare.12885062
title: Supplementary_Methods_2

description: Examples of command lines used to run bioinformatic analysis. Includes the edgeR script to conduct DE gene analysis and examples of lines used to generate the plots.
DOI: 10.6084/m9.figshare.12885062.v1
title: Supplementary_Methods_2

description: Examples of command lines used to run bioinformatic analysis. Includes the edgeR script to conduct DE gene analysis and examples of lines used to generate the plots.
DOI: 10.6084/m9.figshare.6269726
title: Fig. 6

description: quality factor
DOI: 10.6084/m9.figshare.12885104.v1
title: Dataset_S2

description: Calculations of delta Ct values for the five Spiroplasma RIP genes. Results for each strain (Uganda or Brazil) are reported in separate worksheets. In addition one worksheet contains the summarized results of both strains.
DOI: 10.6084/m9.figshare.12885119.v1
title: Dataset_S3

description: Dataset S3. D. melanogaster and Spiroplasma count tables. The main folder contains three subfolders:<br> D.mel_T1_counts: contain Drosophila count tables for each of the treatments collected at Time Point 1 (24h PWA). <br>D.mel_T2_counts, contains Drosophila count tables for each of the treatments collected at Time Point 2 (72h PWA).<br>Spiroplasma_counts: contains the count tables of Spiroplasma. Two files in this folder contain the counts for all Spiroplasma treatments divided by time. For additional information see README text files inside each folder.
DOI: 10.6084/m9.figshare.12885119
title: Dataset_S3

description: Dataset S3. D. melanogaster and Spiroplasma count tables. The main folder contains three subfolders:<br> D.mel_T1_counts: contain Drosophila count tables for each of the treatments collected at Time Point 1 (24h PWA). <br>D.mel_T2_counts, contains Drosophila count tables for each of the treatments collected at Time Point 2 (72h PWA).<br>Spiroplasma_counts: contains the count tables of Spiroplasma. Two files in this folder contain the counts for all Spiroplasma treatments divided by time. For additional information see README text files inside each folder.
DOI: 10.6084/m9.figshare.12885095.v1
title: Dataset_S1

description: Recovered read sequences that mapped to the 28S rRNA region of L. heterotoma (Lh) or G. hookeri (Gh), of Spiroplasma-infected (S+) or and uninfected (S0) treatments, at T1= 24h post wasp attack and T2= 72h post wasp attack (Geneious-formatted file)
DOI: 10.6084/m9.figshare.12885074.v2
title: Table_S3

description: Values of depurination in the 28S rRNA sequences of L. heterotoma or G. hookeri. Number of adenines or other bases in the specific site of RIP attack in the presence of Spiroplasma-L. heterotoma(S+Lh), Spiroplasma-G. hookeri(S+Gh) or in absence of Spiroplasma (S0Lh and S0Gh), respectively. The two times of parasitism were evaluated, T1=24h PWA and T2=72 PWA
DOI: 10.6084/m9.figshare.12885104
title: Dataset_S2

description: Calculations of delta Ct values for the five Spiroplasma RIP genes. Results for each strain (Uganda or Brazil) are reported in separate worksheets. In addition one worksheet contains the summarized results of both strains.
DOI: 10.6084/m9.figshare.12885095
title: Dataset_S1

description: Recovered read sequences that mapped to the 28S rRNA region of L. heterotoma (Lh) or G. hookeri (Gh), of Spiroplasma-infected (S+) or and uninfected (S0) treatments, at T1= 24h post wasp attack and T2= 72h post wasp attack (Geneious-formatted file)
DOI: 10.6084/m9.figshare.12885074.v1
title: Table_S3

description: Values of depurination in the 28S rRNA sequences of L. heterotoma or G. hookeri. Number of adenines or other bases in the specific site of RIP attack in the presence of Spiroplasma-L. heterotoma(S+Lh), Spiroplasma-G. hookeri(S+Gh) or in absence of Spiroplasma (S0Lh and S0Gh), respectively. The two times of parasitism were evaluated, T1=24h PWA and T2=72 PWA
DOI: 10.6084/m9.figshare.6269726.v1
title: Fig. 6

description: quality factor
DOI: 10.6084/m9.figshare.6269720
title: Fig5

description: Resistance
DOI: 10.6084/m9.figshare.6269720.v1
title: Fig5

description: Resistance
DOI: 10.6084/m9.figshare.6269705
title: Data repository Hypoxia, Exercise and Attention

description: The Frankfurt Attention Inventory 2 (FAIR-2) was performed at four testing points (D1, 14, 16, 18). 80 participants were assigned to 4 groups (HYP+EX, HYP, EX, and NOR).HYP = hypoxia; EX = exercise, NOR = normoxia<br>
DOI: 10.6084/m9.figshare.6269690
title: Supplementary Material for: Fragebogen zur Beanspruchung von Zahnärzten im Praxisalltag

description: No Abstract
DOI: 10.6084/m9.figshare.6269690.v1
title: Supplementary Material for: Fragebogen zur Beanspruchung von Zahnärzten im Praxisalltag

description: No Abstract
DOI: 10.6084/m9.figshare.6269687
title: Supplementary Material for: Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features

description: <b><i>Background and Aims:</i></b> The purpose of our study was to examine the histopathologic characteristics of hepatocellular carcinoma (HCC) with irregular rim-like arterial phase enhancement (IRE), which has been reported to be associated with more aggressive tumor behavior. <b><i>Methods:</i></b> We investigated 84 pathologically confirmed HCCs in 84 patients who underwent curative hepatic resection after gadoxetate-enhanced magnetic resonance imaging between January 2008 and February 2013. Two abdominal radiologists independently reviewed these images and classified HCCs into two categories: HCC showing IRE (IRE-HCC) and HCC showing hypoenhancement or diffuse arterial enhancement (non-IRE-HCC). Twenty-two HCCs were classified as IRE-HCCs, and 51 were classified as non-IRE-HCCs concordantly by both reviewers. The remaining 11 HCCs, on whose radiologic classifications the reviewers disagreed, were classified as HCCs with intermediate enhancement patterns. The HCC clinicopathologic characteristics and patient outcomes were then compared. <b><i>Results:</i></b> IRE-HCCs showed more frequent microvascular invasion (91 vs. 35%), lower microvascular density (246.5 vs. 426.5/mm<sup>2</sup>), higher proportions of sinusoid-like microvascular pattern (55 vs. 0%) and macrotrabecular pattern (45 vs. 0%), and larger areas of tumor necrosis (15 vs. 0%) and fibrous stroma (8.3 vs. 2.1%) than non-IRE-HCCs. IRE-HCCs also expressed higher levels of immunomarkers of hypoxia (carbonic anhydrase IX, 64 vs. 8%) and stemness (EpCAM, 50 vs. 20%). <i>p</i> values were &lt; 0.001 for all comparisons except for EpCAM (<i>p</i> = 0.026). HCCs with intermediate enhancement patterns showed mixed/intermediate pathologic features from both IRE- and non-IRE-HCCs. IRE-HCC patients showed poorer 5-year disease-free survival after curative resection than non-IRE-HCC patients (<i>p</i> = 0.005). <b><i>Conclusions:</i></b> IRE-HCCs demonstrate aggressive histopathologic features, including more hypoxic and fibrotic tumor microenvironments and increased stemness, compared to non-IRE-HCCs. IRE might therefore serve as a noninvasive imaging biomarker for aggressive HCC.
DOI: 10.6084/m9.figshare.6269687.v1
title: Supplementary Material for: Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features

description: <b><i>Background and Aims:</i></b> The purpose of our study was to examine the histopathologic characteristics of hepatocellular carcinoma (HCC) with irregular rim-like arterial phase enhancement (IRE), which has been reported to be associated with more aggressive tumor behavior. <b><i>Methods:</i></b> We investigated 84 pathologically confirmed HCCs in 84 patients who underwent curative hepatic resection after gadoxetate-enhanced magnetic resonance imaging between January 2008 and February 2013. Two abdominal radiologists independently reviewed these images and classified HCCs into two categories: HCC showing IRE (IRE-HCC) and HCC showing hypoenhancement or diffuse arterial enhancement (non-IRE-HCC). Twenty-two HCCs were classified as IRE-HCCs, and 51 were classified as non-IRE-HCCs concordantly by both reviewers. The remaining 11 HCCs, on whose radiologic classifications the reviewers disagreed, were classified as HCCs with intermediate enhancement patterns. The HCC clinicopathologic characteristics and patient outcomes were then compared. <b><i>Results:</i></b> IRE-HCCs showed more frequent microvascular invasion (91 vs. 35%), lower microvascular density (246.5 vs. 426.5/mm<sup>2</sup>), higher proportions of sinusoid-like microvascular pattern (55 vs. 0%) and macrotrabecular pattern (45 vs. 0%), and larger areas of tumor necrosis (15 vs. 0%) and fibrous stroma (8.3 vs. 2.1%) than non-IRE-HCCs. IRE-HCCs also expressed higher levels of immunomarkers of hypoxia (carbonic anhydrase IX, 64 vs. 8%) and stemness (EpCAM, 50 vs. 20%). <i>p</i> values were &lt; 0.001 for all comparisons except for EpCAM (<i>p</i> = 0.026). HCCs with intermediate enhancement patterns showed mixed/intermediate pathologic features from both IRE- and non-IRE-HCCs. IRE-HCC patients showed poorer 5-year disease-free survival after curative resection than non-IRE-HCC patients (<i>p</i> = 0.005). <b><i>Conclusions:</i></b> IRE-HCCs demonstrate aggressive histopathologic features, including more hypoxic and fibrotic tumor microenvironments and increased stemness, compared to non-IRE-HCCs. IRE might therefore serve as a noninvasive imaging biomarker for aggressive HCC.
DOI: 10.6084/m9.figshare.6269681
title: data set

description: Screenshots from a Chinese social networking site<br>
DOI: 10.6084/m9.figshare.6269681.v1
title: data set

description: Screenshots from a Chinese social networking site<br>
DOI: 10.6084/m9.figshare.6269321
title: Characterization of deep neural network features by decodability from human brain activity

description: We present a dataset derived through the DNN feature decoding analyses (Horikawa and Kamitani, 2017), including true and decoded feature values of DNNs (AlexNet and VGG19) and decoding accuracies of individual DNN features with their rankings. The decoding accuracies of individual DNN features were highly correlated across subjects, suggesting the systematic differences between the brain and DNNs. The unpreprocessed fMRI data is available from the OpenNeuro (https://openneuro.org/datasets/ds001246). We hope the present dataset will contribute to reveal the gap between the brain and DNNs and provide an opportunity to make use of the decoded features for further applications.
DOI: 10.6084/m9.figshare.6269321.v1
title: Characterization of deep neural network features by decodability from human brain activity

description: We present a dataset derived through the DNN feature decoding analyses (Horikawa and Kamitani, 2017), including true and decoded feature values of DNNs (AlexNet and VGG19) and decoding accuracies of individual DNN features with their rankings. The decoding accuracies of individual DNN features were highly correlated across subjects, suggesting the systematic differences between the brain and DNNs. The unpreprocessed fMRI data is available from the OpenNeuro (https://openneuro.org/datasets/ds001246). We hope the present dataset will contribute to reveal the gap between the brain and DNNs and provide an opportunity to make use of the decoded features for further applications.
DOI: 10.4225/03/5afab6b632ab5
title: Supplementary Figure 8

description: confocal microscopy image series
DOI: 10.6084/m9.figshare.6269192
title: Data Accompanying "Vertical distribution of aerosols over the Maritime Continent during El Niño"

description: AOD_MODISXXX06_FireCorrected_Ver6 files are processed, cloud cleared, AOD files for the month XXX in the year 2006, over the region given in Figure 1.<br>XXX06_10to90_HeightCorrected files are processed, cloud and error cleared, CALIOP data files for the month XXX in the year 2006 over the region given in Figure 1.<br><br>XXX06_Sensitivity_Analysis_V6 dies are processed, model results from the plume rise model, for the month XXX in the year 2006 over the region given in Figure 1.<br>
DOI: 10.6084/m9.figshare.6269192.v1
title: Data Accompanying "Vertical distribution of aerosols over the Maritime Continent during El Niño"

description: AOD_MODISXXX06_FireCorrected_Ver6 files are processed, cloud cleared, AOD files for the month XXX in the year 2006, over the region given in Figure 1.<br>XXX06_10to90_HeightCorrected files are processed, cloud and error cleared, CALIOP data files for the month XXX in the year 2006 over the region given in Figure 1.<br><br>XXX06_Sensitivity_Analysis_V6 dies are processed, model results from the plume rise model, for the month XXX in the year 2006 over the region given in Figure 1.<br>
DOI: 10.6084/m9.figshare.6269189
title: plos_data_ABILITY.xlsx

description: Anonymized (or de-identified) primary patient-level data that underlie the findings described in the article "Predictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study" published in PLOS ONE (https://doi.org/10.1371/journal.pone.0171723).
DOI: 10.6084/m9.figshare.6269189.v1
title: plos_data_ABILITY.xlsx

description: Anonymized (or de-identified) primary patient-level data that underlie the findings described in the article "Predictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study" published in PLOS ONE (https://doi.org/10.1371/journal.pone.0171723).
DOI: 10.6084/m9.figshare.6269147
title: Supplementary Material for: Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival

description: Psoriasis is a complex and chronic disease, and, in most cases, therapies are required during all patients’ lifetime. The efficacy and safety profiles of biological therapies are well established, but their effectiveness is still open to discussion. We performed a systematic review to summarize how the effectiveness of biological therapies for psoriasis is measured in real-world studies and to understand whether drug survival, a recent alternative outcome to clinical ones, is a recurrent and valid outcome of effectiveness. In March 2017, we searched for quantitative epidemiological data of psoriasis treatments using PubMed/Medline and EMBASE, and we included 65 publications. The retrospective study design (37%) was most frequent, followed by prospective registries (29%), prospective studies (19%), and retrospective administrative databases/claims. Drug survival was reported in over 60% of prospective registries and retrospective studies, and less frequently in prospective studies. A general consensus emerged in the definition of drug survival as the time patients remain under treatment with a specific therapy, and in its interpretation as an overall marker of treatment success and treatment adherence, as it represents simultaneously information on drug efficacy, drug safety, and patient satisfaction. In conclusion, notwithstanding some limitations, drug survival is a useful measurement of biological therapy effectiveness for psoriasis in daily practice. Its major advantage is that it can be computed also in already collected databases without any specific clinical information on psoriasis. This outcome, combined with evidence on clinical markers of effectiveness, can contribute to better understanding the performance of this expensive class of drugs.